Cargando…
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
Oncolytic viruses (OVs) are an emergent and unique therapy for cancer patients. Similar to chemo- and radiation therapy, OV can lyse (kill) cancer cell directly. In general, the advantages of OVs over other treatments are primarily: a higher safety profile (as shown by less adverse effects), ability...
Autores principales: | Pelin, Adrian, Wang, Jiahu, Bell, John, Le Boeuf, Fabrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880516/ https://www.ncbi.nlm.nih.gov/pubmed/29637059 http://dx.doi.org/10.2147/OV.S137159 |
Ejemplares similares
-
Targeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia Virus
por: Kirn, David H, et al.
Publicado: (2007) -
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
por: Ungerechts, Guy, et al.
Publicado: (2016) -
Development and applications of oncolytic Maraba virus vaccines
por: Pol, Jonathan G, et al.
Publicado: (2018) -
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models
por: Le Boeuf, Fabrice, et al.
Publicado: (2017) -
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
por: Bourgeois-Daigneault, Marie-Claude, et al.
Publicado: (2016)